Novo Nordisk submits application for massive manufacturing campus near Dublin

Two weeks ago, Novo Nordisk confirmed a report about its purchase of an Alkermes pill factory in Athlone, Ireland. That 85 million euro move ($92.5 million U.S.), now appears to be an appetizer for what the Danish company plans to build just 120 kilometers east, near Dublin, as it tries to meet the skyrocketing demand for its GLP-1 diabetes and weight-loss drugs Ozempic and Wegovy.